Biocon Biologics obtains USFDA approval for biosimilar Aflibercept
Yesafili enters U.S. market to treat ophthalmology conditions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
USFDA
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 mL
Sucralfate is used to treat stomach ulcers, GERD, radiation proctitis, and stomach inflammation and to prevent stress ulcers.
Cipla gains USFDA approval for the generic version of Somatuline Depot (Lanreotide) injection
The new generic version to treat patients with GEP-NETs
Glenmark receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution,…
Glenmark’s Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% has been determined by the FDA to be…
USFDA concludes inspection of Indoco’s Rabale facility
The inspection concluded with zero Form 483 observations
Lupin receives USFDA approval for Midostaurin Capsules
Midostaurin Capsules, 25 mg, are indicated to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated…
Zydus receives USFDA approval for Dexamethasone
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye…
Strides receives USFDA approval for Sevelamer Carbonate Tablets
Sevelamer Carbonate is a phosphate binder that helps prevent hypocalcemia (low levels of calcium in the body) caused by elevated…
Alembic Pharmaceuticals receives five US FDA product approvals in Q1FY25
Receives 3 final and 2 tentative product approvals thus far in Q1FY25
US FDA to Review Eli Lilly’s Donanemab for Early Alzheimer’s Treatment
The meeting is set to be held on June 10, 2024